---
title: "Dolby Laboratories (DLB.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DLB.US/norm.md"
symbol: "DLB.US"
name: "Dolby Laboratories"
parent: "https://longbridge.com/en/quote/DLB.US.md"
datetime: "2026-03-13T01:08:53.127Z"
locales:
  - [en](https://longbridge.com/en/quote/DLB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DLB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DLB.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/DLB.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/DLB.US/norm.md)


# Dolby Laboratories (DLB.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.5500 | 0.5121 | 0.4800 | 0.9400 | 0.7000 |
| ROE | 8.18% | 7.55% | 7.12% | 14.45% | 10.88% |
| Revenue | 346.71M | 307.02M | 315.55M | 369.56M | 357.00M |
| Net income | 53.33M | 49.33M | 46.07M | 91.79M | 67.82M |
| Operating income | 72.63M | 35.80M | 47.09M | 111.97M | 85.10M |
| Gross margin | 87.54% | 87.13% | 86.06% | 90.30% | 88.58% |
| Net margin | 15.38% | 16.07% | 14.60% | 24.84% | 19.00% |
| Profit quality | 132.53% | 29.15% | 69.57% | 64.02% | 79.69% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 3.19B | 3.23B | 3.20B | 3.23B | 3.16B |
| Leverage | 1.23 | 1.23 | 1.22 | 1.25 | 1.25 |
| BVPS | 27.15 | 27.47 | 27.19 | 26.79 | 26.03 |
| Turnover | 0.4216 | 0.4257 | 0.4366 | 0.4209 | 0.4316 |
| Cash & STI | 644.58M | 702.60M | 699.33M | 626.55M | 520.82M |
| Inv & Rec | 31.26M | 30.42M | 32.41M | 34.59M | 31.83M |
| LT assets | 502.29M | 503.81M | 511.43M | 506.75M | 513.09M |
| Net debt | -603.95M | -663.72M | -660.22M | -586.12M | -476.38M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 54.80M | 122.83M | 67.69M | 174.90M | 106.78M |
| Investing CF | 1.25M | -21.91M | -6.43M | 25.89M | -8.14M |
| Financing CF | -121.83M | -64.06M | -60.74M | -64.87M | -57.57M |
| Free CF | 38.62M | 58.86M | 133.19M | 136.69M | 79.92M |
| OCF coverage | 140.63% | 256.79% | 177.85% | 451.63% | 278.60% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -4.63M | -16.24M | -6.43M | -6.90M | -6.78M |

## Distribution Plan

**Dividend Yield**: 2.19

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.36USD | 2026-02-10 | 2026-02-10 | 2026-02-18 |
| Cash Dividend: 
0.36USD | 2025-12-02 | 2025-12-02 | 2025-12-10 |
| Cash Dividend: 
0.33USD | 2025-08-12 | 2025-08-12 | 2025-08-20 |